ORG Wealth Partners LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 45.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 771 shares of the healthcare conglomerate’s stock after buying an additional 241 shares during the period. ORG Wealth Partners LLC’s holdings in UnitedHealth Group were worth $405,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in UNH. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $6,375,744,000. GAMMA Investing LLC boosted its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Amundi boosted its holdings in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several analysts have commented on UNH shares. Wells Fargo & Company restated an “overweight” rating on shares of UnitedHealth Group in a report on Friday, June 6th. Truist Financial reaffirmed a “buy” rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Royal Bank Of Canada decreased their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Finally, Mizuho decreased their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $426.52.
UnitedHealth Group Stock Down 0.6%
UNH opened at $306.90 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The firm’s fifty day moving average is $370.86 and its 200 day moving average is $467.96. The stock has a market cap of $278.40 billion, a price-to-earnings ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the firm posted $6.91 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. UnitedHealth Group’s payout ratio is 37.02%.
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer now directly owns 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last three months. Insiders own 0.28% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Amazon Could Be About To Breakout To $250
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- What Are Trending Stocks? Trending Stocks Explained
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.